Inolex CHA FAQ Questions
Q: Is CHA banned for use in cosmetics in Canada?
A: No. CHA is not banned for use in cosmetics in Canada. Inolex products containing CHA are approved for cosmetic use in Canada according to Ministerial Condition No. 20655.
There are multiple Ministerial Conditions related to CHA in Canada with different conclusions, but Inolex products are only covered by one, No. 20655, and that conclusion is “cosmetic use permitted under certain restrictions”.Q: Does CHA have use level restrictions in Canada?
A: In certain cases, yes. There are use level and application restrictions for Inolex products containing CHA, but they only apply to Inolex and Inolex customers importing the products into Canada directly from Inolex. If you are not importing a CHA containing product directly from Inolex into Canada, these use level and application restrictions do not apply to you.
If you are unsure what your import status will be once you launch your product, please contact your sales representative or info@inolex.com to get more information so you can make the best choices about use level and applications.Q: What is the recommended use level for CHA?
A: The CIR and CA NHPID recommend a maximum use level of 0.3% Caprylhydroxamic Acid in cosmetic formulations. All individual Inolex products containing CHA have recommended use levels aligned to these recommendations. You can view an individual products’ use level recommendations on inolex.com and in the Product Bulletin.
Additional resources to learn more about Ministerial Conditions
Ministerial Condition No. 20655Cosmetic Alliance Canada, Regulatory Bites – Ministerial Conditions
This technical product information and suggestions for use, while believed to be accurate and reliable, is given without any guarantee or warranty of any kind expressed or implied. Purchaser assumes all risk in acting on this information provided by Inolex Inc. and its representatives. Since product specifications may have individual requirements based on customer’s specific needs, each purchaser is urged to perform their own tests, experiments, and investigations in the use of Inolex Inc. products and for purposes of determining compliance with applicable local laws and regulations. Inolex Inc. and its representatives assume no liability in connection with the use or utilization of the materials or the products described therein. Nothing stated herein is to be considered a recommendation or inducement of any use, manufacture, or sale that may infringe any patents or any other proprietary rights now or hereafter in existence. Moreover, no license is to be implied under any Inolex patents relating to the uses of the above.
Related News

Honoring the Life and Legacy of Conrad A. Plimpton
April 2026Conrad A. Plimpton, longtime Chairman and CEO of Inolex and a respected leader in the global personal care industry, passed away on April 19 at the age of 83. A visionary deal maker and entrepreneur with a deep passion for applied science, Conrad led the 1981 buyout of Inolex and helped shape it into the independent, multigenerational ingredient design firm it is today.

Inolex Appoints Rishabh Shah Director of R&D, Applications & Technical Service
April 2026Industry veteran with over 15 years of experience in formulation science, technical service, and customer-driven innovation.

Inolex Appoints Nancy Appelquist Director of Supply Chain
March 2026Industry veteran with over two decades of experience leading operations, strategy and team development.